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Introduction
Pathologic myopia is a leading cause of visual impairment. 1, 2 In highly myopic eyes, the elongation of axial length of the eye and the development of a posterior staphyloma result in a thinning of the retina and choroid, which then lead to the development of different types of myopic traction maculopathy. 2, 3 Important causative factors might be related to the tangential traction caused by the premacular membrane or fibrosis and the inverse traction caused by the posterior staphyloma. [3] [4] [5] A non-rhegmatogenous retinal detachment in highly myopic eyes was first reported by Phillips and associates in 1958 as a posterior retinal detachment with no macular hole. 6 Subsequently, optical coherence tomography (OCT) showed that myopic traction maculopathy was a combination of a foveal retinal detachment and a foveal schisis. 2, 3 Using OCT, Takano and Kishi reported that foveal retinoschisis or foveal retinal detachment occurs frequently in severely myopic eyes even in the absence of a macular hole. 7 They suggested that the retinal detachment may precede the formation of a macular hole in highly myopic eyes. A foveal detachment and macular retinoschisis have been reported to be significantly associated with the presence of a posterior staphyloma. 8, 9 Shimada et al 10 showed the progression of a retinoschisis to a foveal detachment, and Sayanagi et al 11 reported that a foveal detachment progressed to a macular hole retinal detachment (MHRD). A myopic tractional maculopathy has three stages of Taniuchi S, et al Vitrectomy for myopic traction maculopathy 5 development. It begins as a macular retinoschisis, referred to as macular retinoschisis instead of foveal schisis or foveoschisis, followed by the development of a foveal detachment which subsequently progresses to a macular hole and a MHRD. [10] [11] [12] The myopic traction maculopathy was believed to cause by an anterior-posterior traction of the vitreous on the macula. More recent analysis by OCT showed that a tangential traction of the vitreous cortex behind a vitreous pocket contributed to the development of myopic traction maculopathy. [3] [4] [5] 7 Removal of the adherent vitreous cortex without removing the internal limiting membrane (ILM) has been shown to be effective in treating myopic traction maculopathy, suggesting that vitrectomy should be performed as a prophylactic treatment in highly myopic eyes at high risk of macular hole development. [13] [14] [15] [16] [17] Ikuno and associates 18 reported that retinal microfolds are common in eyes with myopic macular retinoschisis after vitrectomy with ILM peeling, and the microfolds appeared to be generated by insufficient flexibility of the sclerotic retinal arterioles during axial length elongation in highly myopic eyes. They suggested that retinal arteriolar traction is a possible cause of myopic macular retinoschisis. Thus, posterior vitreous traction, epiretinal membrane, ILM traction, and inflexibility of the retinal vessels associated with posterior staphyloma are believed to be major causes of myopic macular retinoschisis and foveal detachment without retinal breaks. 3 Histological studies of excised posterior vitreous cortex in eyes with a MHRD in highly myopic eyes have shown that fibrous astrocytes made up the majority of cells, and the Taniuchi S, et al  Vitrectomy for myopic traction maculopathy   6 cortical vitreous contained abundant newly-formed collagen including fibrous, long-spacing collagen surrounded by sparsely distributed native vitreous collagen. 19 These findings indicate that removal of the vitreous cortex should reduce the tangential traction and resolve the myopic traction maculopathy.
Removal of the ILM has been reported to remove vitreous traction on the retina more completely. [20] [21] [22] [23] Ultrastructural study showed collagen fibers and cell debris on the inner surface of excised ILM in the eyes with myopic macular retinoschisis. 24 However, removal of the ILM may increase the incidence of postoperative complications including development of macular hole and MHRD. 20 In addition, there are no comparative studies as far as we have searched in PubMed that examined the efficacy of removing ILM on the BCVA and the anatomical outcome.
Thus, the purpose of this study was to evaluate the postoperative BCVA and complications after vitrectomy on eyes at different stages of myopic traction maculopathy.
We also examined the effect of ILM peeling for postoperative visual outcome and the incidence of intraoperative and postoperative complications.
Patients and Methods
We reviewed the medical records of 71 eyes from 64 patients (14 men and 50 women) that had undergone vitrectomy for myopic traction maculopathy at the Kyorin Eye Center from September 1998 to February 2011. Vitrectomy was performed in patients with 
Results
The mean age of all patients was 65.5 ± 8.6 years with a range of 46 to 88 years, and the mean follow-up period was 27.7 ± 25.9 months with a range of 13 to116 months. The There were 26 eyes (37%) placed in the MR group, 30 eyes (42%) in the FD group, and 15 eyes (21%) in the MH group. A gas tamponade was used in 43 eyes, air in 6 eyes, SF6 in 33 eyes, and C3F8 in 4 eyes. Silicon oil was injected into 6 eyes of 6 patients because these patients had difficulty maintaining a prone position or had poor vision in the fellow eye.
Postoperative Visual Improvement in each type of myopic traction maculopathy
The mean preoperative BCVA was 0.67 ± 0.42 logMAR units, and the mean postoperative BCVA was 0.49 ± 0.38 logMAR units at one year and 0.43 ± 0.38 logMAR units at the final visit. The improvements in the BCVA were significant (P = 0.0021, P = 0.0002, Wilcoxon signed-rank test, respectively). In 11 eyes with reduced BCVA at the final visit, an unclosed macular hole was found in 2 eyes and a development of a macular hole in one eye in the MR group. A MHRD developed in one eye and an enlargement of a chorioretinal atrophy with or without choroidal neovascularization or progression of patchy atrophy in 3 eyes in the FD group and 1 eye in the MH group. Glaucoma developed in one eye in the MR group, the cataract progressed without a need for surgery in one eye in the MR group, and a recurrent traction macular detachment developed in one eye of the MR group.
The age, axial length and preoperative BCVA were not significantly different in the MR, FD, and MH groups (P = 0.206, P = 0.091, P = 0.303, Kruskal-Wallis test, Table 1 ). At postoperative one year, the BCVA significantly improved in the MR and FD groups (P = 0.043, P = 0.017, respectively, Wilcoxon signed-rank test), but not in the MH group (P = 0.208, Figure 1 ). At the final visit, the BCVA significantly improved in the MR and FD groups (P = 0.003, P = 0.010, respectively), but not in the MH group (P = 0.069).
The incidence of postoperative BCVA of better than 20/40 at one year was significant in three groups; the MR group (54%), the FD group (48%), and the MH group (13%, P = 0.032, Kruskal-Wallis test; Figure 2 ). The incidence of postoperative BCVA of better than 20/40 was significantly higher in the MR and FD groups than that of the MH group (P = 0.010, P = 0.021, Steel test, respectively). The incidence of postoperative BCVA of better than 20/40 at the final visit increased in all groups; the MR group (62%), the FD group (53%), and the MH group (27%). The incidence of postoperative BCVA of better than 20/40 at the final visit was also significant in three groups (P = 0.045, Kruskal-Wallis test). The incidence of postoperative BCVA of better than 20/40 was significantly higher in the MR group than that of the MH group (P = 0.029, Steel test), but that of the FD group was not significant with that of the MH group (P = 0.077).
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Visual improvements with or without internal limiting membrane peeling
The age, sex, axial length, types of myopic traction maculopathy, and incidence of cataract surgery were not significantly different whether the ILM was peeled or not peeled ( Table 2 The BCVA in eyes with ILM peeling at the final visit was also not significant with that in eyes without ILM peeling (0.40 ± 0.36 logMAR units, 0.65 ± 0.48 logMAR units, respectively, P = 0.128). The BCVA in eyes with ILM peeling was significantly better at one year and at the final visit comparing to that at baseline (P = 0.001, P < 0.001, respectively, Wilcoxon signed-rank test). In contrast, the BCVA in eyes without ILM peeling at one year or at the final visit was not significant with that at baseline (P = 0.647, P = 0.386, respectively).
The BCVA in the MR group with ILM peeling was not significant at one year with that at the baseline (P = 0.050, Wilcoxon signed-rank test) but was significantly better at the final visit (P = 0.003, Figure 3 ). The BCVA in the FD group with ILM peeling was significantly better at one year and at the final visit comparing to that at baseline (P = 0.017, P = 0.010, respectively). In contrast, the BCVA in the MH group with ILM peeling at one year or at the final visit was not significant with that at baseline (P = 0.208, P = Taniuchi S, et al Vitrectomy for myopic traction maculopathy 0.069, respectively).
Intraoperative complications
The incidence of intraoperative retinal breaks was 2 eyes (7.7%) in the MR group, 4 eyes (13.3%) in the FD group, and 2 eyes (13.3%) in the MH group (P = 0.795, Fisher exact probability test). These retinal breaks were located at the periphery or around the vascular arcade. A macular hole developed in 6.7% in the FD group but none in the MR group (P = 0.282, comparison in 2 groups). These macular holes in the FD group were found when the vitreous cortex was peeled.
Postoperative complications
Postoperative tractional macular detachment developed after resolution of myopic traction maculopathy without any sign of proliferative vitreoretinopathy in one eye (3.8%) in the MR group and 2 eyes (6.7%) in the FD group (P = 0.795, Fisher exact probability test; Figure 4) . A postoperative macular hole developed in one eye (3.8%) in the MR group, 4 eyes (26.7%) in the MH group, and none in the FD group (P = 0.003). In 4 eyes in the MH group with a postoperative macular hole, the macular hole was not closed after the initial surgery with air or SF6 gas tamponade in 2 eyes and these eyes were followed without any surgical intervention. In the other 2 eyes in the MH group, the macular hole was closed after the initial surgery but reopened 1 and 5 months after the surgery with silicon oil or C3F8 gas tamponade. A MHRD developed in 4 eyes Of the 61 eyes in which the ILM was removed, a MHRD developed in 5 eyes (8%) at 2 to 4 weeks, a macular hole in 3 eyes (5%) at one month, and a rhegmatogenous retinal detachment in 3 eyes (5%) at postoperative 3, 7, and 9 months. However, a tractional retinal detachment did not develop in any eye after ILM peeling (Table 2) . The other eye was not reoperated but followed. The incidence of tractional detachment was significantly lower in eyes with ILM peeling (P=0.018, Fisher exact probability test) although the incidences of the other complications were not significantly different (macular hole; P = 1.000, MHRD; P = 0.254). In addition, postoperative formation of macular hole seemed to accelerate after ILM was peeled because all 3 eyes with postoperative macular hole developed at one month in eyes with ILM peeled and one eye at 4 years in eye with ILM not peeled (P = 0.25).
A MHRD developed within one month after surgery in eyes with and without ILM peeling.
In contrast, a macular hole and a tractional detachment developed within a year after surgery in eyes with ILM peeling but more than 2 years after surgery in eyes without ILM peeling (P = 0.859, P = 0.018, respectively).
Relationships between patient baseline characteristics and postoperative vision at final visit
The patient baseline characteristics that were significantly associated with the BCVA at the final visit were age (P = 0.026) and ILM peeling (P = 0.034; Table 3 ). The sex, preoperative BCVA, axial length, type of myopic traction maculopathy, and preoperative BCVA were not significantly associated.
Discussion
A myopic macular schisis has been reported to be stable without affecting the visual acuity. 12 However, the risk of a reduction of the BCVA is higher when the macular schisis was combined with a premacular epiretinal membrane or a residual attachment of the posterior hyaloid to the fovea. 12 Eyes with a foveal detachment had better improvements in the BCVA after vitrectomy with ILM peeling for myopic traction maculopathy than eyes with a retinoschisis or a macular hole. 25 Consequently, vitrectomy has been recommended when patients develop a foveal detachment with Taniuchi S, et al Vitrectomy for myopic traction maculopathy symptomatic visual impairiments. 25, 26 The development of a macular hole or a MHRD is a major complication that is associated with poor postoperative vision. 17, 20 Our results showed that a macular hole developed intraoperatively but not postoperatively in the FD group although a MHRD did develop postoperatively in this group. On the other hand, when myopic macular retinoschisis is combined with a foveal detachment, a macular hole developed frequently whether surgery is or is not performed. 12 Our results showed that vitrectomy was effective in treating myopic traction maculopathy with significant improvements of the postoperative BCVA. The improvement in the BCVA in the MR and the FD groups was significant at postoperative one year but not in the MH group. Ikuno and associates 25 described significant visual improvements at 12 months after vitrectomy for myopic traction maculopathy in the FD group but was not significant in MR and MH groups. However the BCVA significantly improved in the MR and FD groups at the final visit in our study. When myopic traction maculopathy progressed to a MH stage, it is difficult to achieve a significant improvement in the postoperative BCVA. 25 In contrast, a postoperative BCVA ≥ 20/40 was achieved more frequently in the earlier stage of myopic traction maculopathy. Thus, the incidence of eyes with a BCVA ≥ 20/40 was found in the following order; MR type > FD type > MH type. 10, 11 The incidence of postoperative BCVA ≥ 20/40 was significantly more frequent in the MR group than that of the MH group at one year and the final visit. In addition, forward stepwise regression analyses showed that the postoperative BCVA at the final visit was significantly correlated with the patients' age and also with ILM peeling but not with the preoperative BCVA and axial length. From these findings, we recommend that younger patients have vitreous surgery with ILM peeling when they develop a macular retinoschisis with reduced BCVA or symptomatic visual impairments. However, a better postoperative BCVA has been reported to be correlated with a better preoperative BCVA and a shorter axial length. [25] [26] [27] Macular hole detected intraoperatively in the FD group and these macular holes may have existed preoperatively, and the preoperative OCT failed to detect the macular holes covered with premacular fibrosis. The incidences of intraoperative and postoperative complications were not significantly different whether the ILM was peeled or not peeled but a recurrence of tractional macular detachment was significantly more frequent in eyes without ILM peeling. These recurrences were observed 2 to 2.5 years after the surgery. Additional vitrectomy involving the removal of the ILM was performed on one of the eyes, and no recurrence of tractional macular detachment was observed for up to 5 years after the second surgery. These recurrences may be caused by cellular proliferation on the residual ILM at long time after the surgery.
The recurrent premacular membrane that developed after the initial vitrectomy without ILM peeling consisted of the ILM and proliferated cells with many dense, intracytoplasmic granules, cytoplasmic processes, and basal lamina. These lamellar or full-thickness paravascular retinal breaks in highly myopic eyes may cause cellular proliferation on the ILM even after a complete removal of the vitreous cortex during the initial vitrectomy. Vitrectomy and ILM peeling and a gas tamponade led to a more rapid anatomical resolution of myopic traction maculopaty and greater improvement in BCVA than that without gas tamponade. 22, 23 These results can be explained by the effects of the gas tamponade for paravascular lamellar or full-thickness retinal breaks that led to a more rapid resolution of a myopic macular retinoschisis.
The limitations of this study were its retrospective design without randomization of the groups. In addition, the number of patients in each group was small and not equal.
Therefore, further studies with larger sample sizes are needed to confirm these results.
In conclusion, the improvement in the BCVA was equal in each stage of myopic traction maculopathy. However, better postoperative BCVA was achieved significantly more frequently when the vitrectomy is performed at a MR or a FD stage of myopic traction maculopathy. ILM removal for myopic traction maculopathy led to significantly better BCVA and prevented recurrent tractional retinal detachment. However, the prevention of the development of intraoperative and postoperative macular hole and postoperative MHRD should be considered during and after surgery because postoperative formation of macular hole tends to develop at an earlier period after ILM is peeled. 10, 12, 17, 20 A new Kruskal-Wallis test, †: Fisher exact probability test Student t-test, †: Fisher exact probability test, ‡: Mann-Whitney U test 
